Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for ACADIA Pharmaceuticals Inc. (ACAD)

« Back to company index

ACAD Chatter Timeline

Stock Ticker for ACAD

Most Active Tweeters for ACAD

UserTweets
@A1Syad 7
@ForTheRecord01 5
@MarcJacksonLA 3
@saltadogato 2
@Tickeron 2

Recent Tweets for ACAD

A1Syad @A1Syad
$ACAD Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/oi0sDGRY1X
2:12am
Gambiste1 @Gambiste1
RT @saltadogato: Interesting that we haven’t heard from $ACAD yet on their Rett Syndrome drug, it seems the study concluded on 10/28/21 (ht…
December 3rd 2021, 6:12am
saltadogato @saltadogato
Interesting that we haven’t heard from $ACAD yet on their Rett Syndrome drug, it seems the study concluded on 10/28… https://t.co/nbY3DPvkyg
December 3rd 2021, 6:12am
vtmtrading @vtmtrading
Acadia Pharmaceuticals participates in a conference call with JPMorgan $ACAD
December 2nd 2021, 10:12pm
ForTheRecord01 @ForTheRecord01
$ACAD If the FDA greenlights an sNDA for Alzheimer's psychosis, then Acadia's stock should easily see a 50-100% spike.
December 2nd 2021, 8:12pm
ForTheRecord01 @ForTheRecord01
December is not exactly a catalyst-rich month for biotech companies, but $ACAD has two coming up: results from a ph… https://t.co/R03nvCwuTm
December 2nd 2021, 8:12pm
A1Syad @A1Syad
$ACAD Awaiting Buy Signal Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/fMmRMccKB9
December 2nd 2021, 8:12pm
MysteriousMole1 @MysteriousMole1
@tappydowm @SicignanoSergio $ACAD has substance. They may need to run additional trials to establish Nuplazid in de… https://t.co/zW3t0KYjDn
December 2nd 2021, 10:12am
gcassidy718 @gcassidy718
$ACAD The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment for Negative Sym… https://t.co/l8kXdj9w9c
December 1st 2021, 7:12pm
Tickeron @Tickeron
$ACAD in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/w9AiXtPzgb
December 1st 2021, 6:12pm
MarcJacksonLA @MarcJacksonLA
$ACAD Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-con… https://t.co/TAPxI008Bt
December 1st 2021, 2:12pm
MarcJacksonLA @MarcJacksonLA
$ACAD The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment for Negative Sym… https://t.co/kksBML7iA8
December 1st 2021, 2:12pm
Zerdoirredento @Zerdoirredento
$ACAD good news reported yet premarket up less than 1%?! ?
December 1st 2021, 2:12pm
otcdynamics @otcdynamics
$ACAD The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment for Negative Sym… https://t.co/zMim0UBVSw
December 1st 2021, 2:12pm
saltadogato @saltadogato
$ACAD - previously reported study of Pimavanserin in schizophrenia published now https://t.co/dXkX1csgPe https://t.co/e2w74Lgzit
December 1st 2021, 2:12pm
phasefivebot @phasefivebot
$ACAD The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment for Negative Sym… https://t.co/dNVkycINZj
December 1st 2021, 2:12pm
vtmtrading @vtmtrading
Acadia Pharmaceuticals publishes data showing ADVANCE met its primary endpoint $ACAD
December 1st 2021, 2:12pm
StckPro @StckPro
$ACAD NEW ARTICLE : The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment fo… https://t.co/HdbZGk9Utk
December 1st 2021, 2:12pm
FlashAlert_me @FlashAlert_me
$ACAD [15s. delayed]: Issued Press Release on December 01, 09:00:00: The Lancet Psychiatry Publishes Results from A… https://t.co/ELY2OqTs25
December 1st 2021, 2:12pm
StockNewsBot2 @StockNewsBot2
$ACAD The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment for Negative Sym… https://t.co/R8yJl6TOCi
December 1st 2021, 2:12pm
stock_titan @stock_titan
$ACAD The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment for Negative Sym… https://t.co/J6TlxXSYAg
December 1st 2021, 2:12pm
A1Syad @A1Syad
$ACAD Awaiting Buy Signal Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/pCyufUA0aO
December 1st 2021, 12:12am
ForTheRecord01 @ForTheRecord01
It's been a dreary and difficult year for biopharma stocks. YTD, as of closing today (11/30): $ACAD: minus 63.64%… https://t.co/zGZopccyeO
November 30th 2021, 11:11pm
ForTheRecord01 @ForTheRecord01
I'd like to see the names of those who put @blakeellis3 and @melhicken up to their hit job on $ACAD back in 2018, a… https://t.co/7fBD1ixLyg
November 30th 2021, 11:11pm
A1Syad @A1Syad
$ACAD Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/OU7n5QW2Xw
November 29th 2021, 7:11pm
MarcJacksonLA @MarcJacksonLA
$ACAD ACADIA Pharmaceuticals Given Average Rating of "Hold" by Analysts | $29.26 Average PT https://t.co/NKb5pRLCDo https://t.co/paN9rVfa4g
November 28th 2021, 5:11pm
A1Syad @A1Syad
$ACAD Time to secure locates to short Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/0bqKAHMJfV
November 26th 2021, 1:11am
SweepCastApp @SweepCastApp
SweepCast alerted: $ACAD with Unusual Options Activity Alerted on $22 CALL Expiring: 01-21-2022 worth 62K? |? Learn… https://t.co/YEBjjcxuK0
November 25th 2021, 5:11pm
SweepCastApp @SweepCastApp
SweepCast alerted: $ACAD with Unusual Options Activity Alerted on $22 CALL Expiring: 01-21-2022 worth 62K? |? Check… https://t.co/3SSFkGlmYy
November 25th 2021, 9:11am
mediasentiment @mediasentiment
$ACAD new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 603
November 24th 2021, 6:11pm
Tickeron @Tickeron
$ACAD in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on November 3, 2021. View odd… https://t.co/JvVRsNMwst
November 24th 2021, 6:11pm
A1Syad @A1Syad
$ACAD Time to secure locates to short Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/1cFkeaQPJy
November 24th 2021, 5:11pm
ForTheRecord01 @ForTheRecord01
$ACAD In early May, advocacy group UsAgainstAlzheimer's criticized the FDA for not approving Nuplazid for dementia-… https://t.co/zHfxg0WXbE
November 24th 2021, 5:11pm
BestThetaTrades @BestThetaTrades
?Expensive Options Alert? $ACAD 30 DTE option chain priced at 88.34% IV PA Forecast indicates it should be 65.32%… https://t.co/TKRfwbl4ts
November 24th 2021, 4:11pm
StockConsultant @StockConsultant
$ACAD ACADIA Pharmaceuticals stock with local support and resistance areas at 17.47, 19.4 and 21.32 , see… https://t.co/4tNTJtR5Lx
November 24th 2021, 1:11pm
formwhisperscom @formwhisperscom
#FWSells $ACAD Stankovic Srdjan R., President of ACADIA PHARMACEUTICALS INC sold 2,803 shares on 2021-11-22. https://t.co/XTJBeFteQG
November 24th 2021, 4:11am
fintel_io @fintel_io
Insider Stankovic Srdjan R. reports selling 2,803 shares of $ACAD for a total cost of $53,285.03 https://t.co/fhedI8mxC2 #FNTL
November 23rd 2021, 11:11pm
A1Syad @A1Syad
$ACAD Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/EFAMKGAEO6
November 23rd 2021, 1:11am
TradeWithAlerts @TradeWithAlerts
A nice print for $ACAD at 5:23pm -- SIDE: Between Click https://t.co/N5HZwF3x73 for more. Runners ?:… https://t.co/9t8vbGjsru
November 22nd 2021, 10:11pm
FlashAlert_me @FlashAlert_me
$ACAD [15s. delayed] filed SEC form 4: Principal Accounting Officer Kihara James: Transacted Derivative Securities… https://t.co/u0qLvD7TGG
November 19th 2021, 11:11pm
FlashAlert_me @FlashAlert_me
$ACAD [15s. delayed] filed SEC form 4: EVP, COO, Head of Commercial Teehan Brendan: Transacted Derivative Securiti… https://t.co/GhTjjZGJ1x
November 19th 2021, 11:11pm
A1Syad @A1Syad
$ACAD Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/3LTE0ehXoV
November 19th 2021, 7:11pm
Tickeron @Tickeron
Good move or bad move? $ACAD Stochastic Oscillator left the oversold zone. #ACADIAPharmaceuticals #stockmarket… https://t.co/KBGQStH7P7
November 18th 2021, 10:11pm
A1Syad @A1Syad
$ACAD So easy to trade with the Short / Buy signals. Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/SaW8paE8BY
November 17th 2021, 11:11pm
Tickeron @Tickeron
$ACAD in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/nExxvo3wdB
November 16th 2021, 11:11pm
TradeWithAlerts @TradeWithAlerts
A nice print for $ACAD at 3:35pm -- SIDE: Bid Click https://t.co/N5HZwF3x73 for more. Runners ?:… https://t.co/nevC9DFKaA
November 16th 2021, 8:11pm
TradeWithAlerts @TradeWithAlerts
A nice print for $ACAD at 3:22pm -- SIDE: Bid Click https://t.co/N5HZwF3x73 for more. Runners ?:… https://t.co/jxv3GAgyoj
November 16th 2021, 8:11pm
MarcJacksonLA @MarcJacksonLA
$ACAD Acadia Pharmaceuticals and StoryCorps Collaborate to Launch Yours, Truly – a Multicultural Storytelling Campa… https://t.co/XauxqzppdN
November 16th 2021, 4:11pm
gcassidy718 @gcassidy718
$ACAD Acadia Pharmaceuticals and StoryCorps Collaborate to Launch Yours, Truly – a Multicultural Storytelling Campa… https://t.co/0ckST5K49o
November 16th 2021, 4:11pm
phasefivebot @phasefivebot
$ACAD Acadia Pharmaceuticals and StoryCorps Collaborate to Launch Yours, Truly – a Multicultural Storytelling Campa… https://t.co/6STcT630wt
November 16th 2021, 2:11pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.